Associate Professor Kuss is the academic head of Genetics and Molecular Medicine at Flinders University and the clinical head of Haematology and Molecular Genetics at SA Pathology, Flinders Medical Centre.
While multiple myeloma is currently deemed incurable, research at Flinders University led by Dr Craig Wallington-Beddoe and Associate Professor Kuss, seeks to find new treatments by targeting a protein on the surface of the cancer cells in the bone marrow. Even patients with the poorest prognosis are set to benefit from this promising research.
“The dream of a cancer treatment that does not require chemotherapy is becoming a reality for some patients with the advent of molecularly targeted therapies,” says Associate Professor Kuss.
Survived by his wife Robyn and children Michael, Alexandra and Elissa, Lee’s family now hope to bring awareness to the insidious disease and to raise funds to support the vital research at Flinders University.
“We are committed to continuing the work he started before being taken, following a long and brave battle with multiple myeloma,” says Lee’s son Michael Virgin.
Flinders University has created the Lee Virgin Fund to directly support the work led by Associate Professor Kuss to improve treatments, care and outcomes for those suffering from multiple myeloma. With donations to the fund from Lee’s friends and supporters already reaching $10,000, the family hopes to achieve $50,000 by the end of the year.
Donate today to help provide better therapies to treat multiple myeloma patients, minimise harmful side effects and improve patient outcomes. 100% of your tax-deductible donation will fund valuable research into multiple myeloma at Flinders University.